These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 6422736

  • 1. Hodgkin's disease. Results from a program in radiation therapy.
    Micaily B, Brady LW.
    Am J Clin Oncol; 1984 Apr; 7(2):159-71. PubMed ID: 6422736
    [Abstract] [Full Text] [Related]

  • 2. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I, Ganser D, Freitag EM, Bohndorf W.
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [Abstract] [Full Text] [Related]

  • 3. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM, Anselmo AP, Donato V, Falchetto Osti M, Santoro M, Tombolini V, Mandelli F.
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [Abstract] [Full Text] [Related]

  • 4. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA, Voss N, Pickles T, Morris J, Gascoyne RD, Savage KJ, Connors JM.
    J Clin Oncol; 2008 Nov 10; 26(32):5170-4. PubMed ID: 18838714
    [Abstract] [Full Text] [Related]

  • 5. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, Silver B, Weinstein H, Come S, Canellos GP, Coleman CN.
    Cancer J Sci Am; 1995 Nov 10; 1(1):33-42. PubMed ID: 9166452
    [Abstract] [Full Text] [Related]

  • 6. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billet AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KC, Rai S, Cowan T, Weinstein HJ.
    J Clin Oncol; 2004 Nov 15; 22(22):4541-50. PubMed ID: 15542805
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
    Yildiz F, Zengin N, Engin H, Güllü I, Barista I, Caglar M, Ozyar E, Cengiz M, Gürkaynak M, Zorlu F, Caner B, Atahan IL, Tekuzman G.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):839-46. PubMed ID: 15465201
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S, Geara F, Nabbout B, Farah RA, Shabb NS, Hajjar T, Khogali M.
    Radiat Oncol Investig; 1999 Nov 01; 7(6):365-73. PubMed ID: 10644060
    [Abstract] [Full Text] [Related]

  • 13. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
    Frank C, Flentje M, Goldschmidt H, Hunstein W, Wannenmacher M.
    Strahlenther Onkol; 1994 Jul 01; 170(7):383-90. PubMed ID: 8052937
    [Abstract] [Full Text] [Related]

  • 14. Pediatric Hodgkin's disease.
    Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM.
    J Ky Med Assoc; 2004 Mar 01; 102(3):104-6. PubMed ID: 15067795
    [Abstract] [Full Text] [Related]

  • 15. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.
    Ai Zheng; 2007 Dec 01; 26(12):1360-4. PubMed ID: 18076802
    [Abstract] [Full Text] [Related]

  • 16. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D, Greenberg M, Fitzgerald A.
    Med Pediatr Oncol; 1996 Jun 01; 26(6):373-9. PubMed ID: 8614372
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P, Bouabdallah R, Moreau P, Divine M, André M, Aoudjane M, Fleury J, Anglaret B, Baruchel A, Sensebe L, Colombat P.
    Bone Marrow Transplant; 1997 Jul 01; 20(1):21-6. PubMed ID: 9232251
    [Abstract] [Full Text] [Related]

  • 18. Definitive irradiation in the treatment of Hodgkin's disease. Analysis of outcome, prognostic factors, and long-term complications.
    Sears JD, Greven KM, Ferree CR, D'Agostino RB.
    Cancer; 1997 Jan 01; 79(1):145-51. PubMed ID: 8988739
    [Abstract] [Full Text] [Related]

  • 19. [Results of the radiotherapy of Hodgkin's disease (a JLRTG report). Japan Lymphoma Radiation Therapy Group].
    Ikeda H, Masaki N, Hayabuchi N, Niibe H, Morita K, Watanabe S, Kaneta K, Horiuchi J.
    Gan No Rinsho; 1988 Apr 01; 34(5):685-92. PubMed ID: 3385934
    [Abstract] [Full Text] [Related]

  • 20. Favorable prognosis after late relapse of Hodgkin's disease.
    Garcia-Carbonero R, Paz-Ares L, Arcediano A, Lahuerta J, Bartolome A, Cortes-Funes H.
    Cancer; 1998 Aug 01; 83(3):560-5. PubMed ID: 9690550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.